Skip to main content
. 2014 Dec 6;11(1):63. doi: 10.1186/s13223-014-0063-8

Figure 1.

Figure 1

Serum IgG levels in A) individual patients and B) mean of patients treated with SCIG. Patients 1 − 10 began treatment with Vivaglobin and later changed to Hizentra. Patients 11 − 13 began and continued treatment with Hizentra. B) Mean serum IgG levels in patients treated with SCIG. Error bars indicate standard deviation. IgG = immunoglobulin G; SCIG = subcutaneous immunoglobulin.